{
  "docId": "019de516-01ce-701d-bd9b-acac15fa9fab",
  "docSlug": "a13be9775a99db49a0c5c2ac3ee2ea88",
  "documentTitle": "Oculis | Investor Conference Presentation Deck | 39 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 31,
  "pageCount": 39,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-01ce-701d-bd9b-acac15fa9fab/31",
  "deckHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab",
  "deckJsonHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab.json",
  "deckAnchorHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab#slide-31",
  "components": [
    {
      "bbox": {
        "h": 0.52,
        "w": 0.49,
        "x": 0.476,
        "y": 0.39
      },
      "kind": "diagram",
      "text": "Survival Foxo3 Apoptosis SGK GSK3B Neuron SGK promotes neuronal survival and differentiation trough Foxo3 and GSK3B OCS-05 SGK NDRG1 Oligodendrocyte SGK induces the cell protective phenotype of microglia (e.g., CNTF production) Cell protective Microglia (M2) CNTF NDRG1 activation by SGK induces Oligodendrocyte Precursors differentiation and myelination",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5dcd84e1-9270-4035-9dee-125b24adf109",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.29,
        "w": 0.29,
        "x": 0.05,
        "y": 0.48
      },
      "kind": "list",
      "text": "Multiple potential applications:\nGlaucoma\nDry AMD / Geographic Atrophy\nDiabetic Retinopathy\nAcute Optic Neuritis\nNeurotrophic Keratitis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c3e5341-fcb0-44c1-a560-8c563b159b3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.099,
        "w": 0.376,
        "x": 0.05,
        "y": 0.242
      },
      "kind": "list",
      "text": "Disease modifying drug to protect and repair neurons\nActivates neurotrophic signalling pathways supporting neuronal survival and repair",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9825acd9-ccfa-4663-a4eb-dcb1dfe73c69",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.44,
        "x": 0.476,
        "y": 0.242
      },
      "kind": "paragraph",
      "text": "Unique & Differentiated MoA\nOCS-05 targets SGK as part of the neurotrophic factor signalling pathways triggering multiple beneficial effects on apoptosis, anti-oxidation and anti-inflammation",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c43e935e-c77c-4de1-be84-5dcc5ccb80ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.834,
        "x": 0.026,
        "y": 0.09
      },
      "kind": "title",
      "text": "SGK-2 activator peptidomimetic small molecule with a unique MoA for neuro-ophthalmology",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ffed12f4-4ec3-4e20-9142-51be105ad5c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.402,
        "x": 0.026,
        "y": 0.049
      },
      "kind": "title",
      "text": "OCS-05 | Candidate Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d2d14d94-22de-412e-81dd-1fdb410f0503",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "5e59ca37-6538-40b2-ba73-092f86c1cb1e",
      "evidence": "list/bullet: Disease modifying drug to protect and repair neurons",
      "confidence": 0.7
    },
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "a944b6bc-7f88-454b-aa84-3eb6f8290187",
      "evidence": "title/action-title: SGK-2 activator peptidomimetic small molecule with a unique MoA for neuro-ophthalmology",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 25,
      "beatId": "6cce666b-f795-4a3e-a589-afe2a7266ece",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 25-39 discuss OCS-02, OCS-05, and the track record of efficient capital deployment.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}